| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.07T | 988.77B | 955.58B | 922.68B | 854.37B |
| Gross Profit | 146.48B | 133.27B | 132.56B | 130.13B | 131.90B |
| EBITDA | 28.46B | 34.19B | 36.43B | 36.70B | 37.51B |
| Net Income | 20.23B | 13.10B | 15.55B | 16.98B | 19.12B |
Balance Sheet | |||||
| Total Assets | 524.73B | 467.01B | 462.57B | 436.76B | 413.12B |
| Cash, Cash Equivalents and Short-Term Investments | 17.98B | 20.99B | 23.23B | 22.74B | 47.99B |
| Total Debt | 62.18B | 62.54B | 43.36B | 45.67B | 37.85B |
| Total Liabilities | 229.21B | 180.69B | 177.24B | 167.50B | 150.38B |
| Stockholders Equity | 294.81B | 285.61B | 284.69B | 268.69B | 262.14B |
Cash Flow | |||||
| Free Cash Flow | -9.54B | -9.35B | 14.76B | -8.50B | 9.43B |
| Operating Cash Flow | 13.66B | 10.02B | 29.39B | 3.95B | 18.47B |
| Investing Cash Flow | -26.01B | -20.64B | -16.01B | -22.93B | -11.25B |
| Financing Cash Flow | 8.52B | 7.47B | -13.28B | -6.84B | -10.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥479.36B | 15.17 | 9.86% | 2.58% | 0.63% | 5.96% | |
67 Neutral | ¥56.64B | 7.19 | 6.48% | 2.27% | 0.88% | ― | |
63 Neutral | ¥610.55B | 15.19 | 6.04% | 2.04% | 4.68% | 16.45% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ¥275.14B | 12.27 | ― | 2.61% | 8.35% | 54.38% | |
47 Neutral | ¥5.54B | 4.87 | ― | ― | -4.74% | 46.95% | |
37 Underperform | ¥1.93B | 5.43 | ― | ― | -3.62% | 10.98% |